Postoperative radiotherapy for uterine cervical cancer: Impact of lymph node and histological type on survival

Anticancer Research

Volumn 33, Issue 5, 2013, Pages 2199-2204

  Kasuya, Goro ^a   Ogawa, Kazuhiko ^b   Iraha, Shiro ^c   Nagai, Yutaka ^a   Hirakawa, Makoto ^a   Toita, Takafumi ^a   Kakinohana, Yasumasa ^a   Kudaka, Wataru ^a   Inamine, Morihiko ^a   Ariga, Takuro ^a   Aoki, Yoichi ^a   Murayama, Sadayuki ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c Department of Radiology   (Japan)

Author keywords

Postoperative radiotherapy; Radiation therapy; Uterine cervical cancer

Indexed keywords

CISPLATIN; IRIDIUM 192;

ABDOMINAL HYSTERECTOMY; ADULT; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CYSTITIS; DRUG MEGADOSE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LEG EDEMA; MAJOR CLINICAL STUDY; MEDICAL RECORD; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PELVIS LYMPH NODE; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; RADICAL HYSTERECTOMY; RECTUM DISEASE; RETROSPECTIVE STUDY; UTERINE CERVIX CANCER;

POSTOPERATIVE RADIOTHERAPY; RADIATION THERAPY; UTERINE CERVICAL CANCER;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PELVIC NEOPLASMS; POSTOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84878196218     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. NCCN Clinical Practice Guidelines in Oncology, Cervical Cancer, Version 1. 275 Commerce Drive, Suite 300, Fort Washington, 2011.
2. Sedlis A, Bundy BN, Rotman MZ, Lentz SS, Muderspach LI and Zaino RJ: A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study. Gynecol Oncol 73: 177-183, 1999. (Pubitemid 29215728)
3. Rotman M, Sedlis A, Piedmonte MR, Bundy B, Lentz SS, Muderspach LI and Zaino RJ: A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: Follow-up of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys 65(1): 169-176, 2006.
4. Peters WA 3rd, Liu PY, Barrett RJ 2nd, Stock RJ, Monk BJ, Berek JS, Souhami L, Grigsby P, Gordon W Jr. and Alberts DS: Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18(8): 1606-1613, 2000. (Pubitemid 30220538)
5. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA 284: 3043-3045, 2000.
6. Pecorelli S, JL Benedet, Creasman WT, Shepherd JH on behalf of the 1994-1997 FIGO Committee on Gynecologic Oncology: FIGO staging of gynecologic cancer. Int J Gynaecol Obset 64(1): 5-10, 1999.
7. Toita T, Moromizato H, Ogawa K, Kakinohana Y, Maehama T, Kanazawa K and Murayama S: Concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer. Gynecol Oncol 96: 665-670, 2005. (Pubitemid 40255485)
8. Toita T, Sakumoto K, Higashi M, Ogawa K, Kakinohana Y, Shinzato S, Moromizato H, Kanazawa K and Sawada S: Therapeutic value of neoadjuvant intra-arterial chemotherapy (cisplatin) and irradiation for locally advanced cervical cancer. Gynecol Oncol 65: 421-424, 1997. (Pubitemid 27255981)
9. Teruya Y, Sakumoto K, Moromizato H, Toita T, Ogawa K, Murayama S and Kanazawa K: High dose-rate intracavitary brachytherapy for carcinoma in situ of the vagina occurring after hysterectomy: a rational prescription of radiation dose. Am J Obstet Gynecol 187: 360-364, 2002. (Pubitemid 34925569)
10. Cox JD, Stetz J and Pajak TF: Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 3: 1341-1346, 1995.
11. LENT SOMA tables. Radiother Oncol 35: 17-60, 1995. (Authors were not published.)
12. Kaplan EL and Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958.
13. Ryu HS, Chun M, Chang KH, Chang HJ and Lee JP: Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients. Gynecol Oncol 96(2): 490-495, 2005. (Pubitemid 40127153)
14. Tsai CS, Lai CH, Wang CC, Chang JT, Chang TC, Tseng CJ and Hong JH: The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy. Gynecol Oncol 75(3): 328-333, 1999.
15. Song S, Song C, Kim HJ, Wu HG, Kim JH, Park NH, Song YS, Kim JW, Kang SB and Ha SW: 20-year experience of postoperative radiotherapy in IB-IIA cervical cancer patients with intermediate risk factors: Impact of treatment period and concurrent chemotherapy. Gynecol Oncol 124(1): 63-67, 2012.
16. Iwasaka T, Kamura T, Yokoyama M, Matsuo N, Nakano H and Sugimori H: Adjuvant chemotherapy after radical hysterectomy for cervical carcinoma: A comparison with effects of adjuvant radiotherapy. Obstet Gynecol 91(6): 977-981, 1998. (Pubitemid 28246935)
17. Delgado G, Bundy BN, Fowler WC Jr., Stehman FB, Sevin B, Creasman WT, Major F, DiSaia P and Zaino R: A prospective surgical pathological study of stage 1 squamous carcinoma of the cervix: A Gynaecologic Oncology Group Study. Gynecol Oncol 35: 314-320, 1989. (Pubitemid 20025893)
18. Takeshima N, Utsugi K, Hasumi K and Takizawa K: Postoperative adjuvant chemotherapy for node-positive cervical adenocarcinoma. Int J Gynecol Cancer 19(2): 277-280, 2009.
19. Kasuya G, Ogawa K, Iraha S, Nagai Y, Shiraishi M, Hirakawa M, Samura H, Toita T, Kakinohana Y, Kudaka W, Inamine M, Ariga T, Nishimaki T, Aoki Y and Murayama S: Severe late complications in patients with uterine cancer treated with postoperative radiotherapy. Anticancer Res 31(10): 3527-3533, 2011.
20. Hasselle MD, Rose BS, Kochanski JD, Nath SK, Bafana R, Yashar CM, Hasan Y, Roeske JC, Mundt AJ and Mell LK: Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 80(5): 1436-1445, 2011.
21. Mundt AJ, Mell LK and Roeske JC: Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. Int J Radiat Oncol Biol Phys 56(5): 1354-1360, 2003. (Pubitemid 36842887)